Association of Papillary Thyroid Carcinoma with GIST—a Case Series

  • Ravindra NidoniEmail author
  • P. J. Halder
  • S. Nikhil
  • Santhosh R
  • Vikesh Kumar
Original Article


Gastrointestinal stromal tumours (GIST) are the most common gastrointestinal mesenchymal tumours of the gastrointestinal tract. They are diagnosed by the expression of markers like CD 117, CD 34, DOG-1 and PDGFRA. The identification of these mutations has resulted in a better understanding of their oncogenic mechanisms. Few studies have shown the high incidence of a second malignancy including papillary thyroid cancer (PTC) in known patients of GIST. Literature review on pathogenesis of GIST and PTC showed that PTC targeting Protein Kinase C theta (PKCθ) plays role in both PTC and GIST. Further studies have also shown that, apart from somatic and familial gastrointestinal stromal tumours, PDGFRA is associated with many other malignancies including PTC. These studies explain the common genetic pathway involved in the development of GIST and PTC in same patient. In spite of common genetic association between GIST and other malignancies, none of the standard protocols recommends screening for second malignancy. In this article, we present the details of four patients who had associated GIST and PTC at the same time or developed during follow-up.


Gastrointestinal stromal tumour (GIST) Papillary thyroid carcinoma KIT mutation PDGFRA Protein kinase C theta (PKCθ) 



  1. 1.
    Rammohan A (2012) A gist of gastrointestinal stromal tumours: a review. World J Gastrointest Oncol 5(6):102–112CrossRefGoogle Scholar
  2. 2.
    Pandurengan R, Dumont A, Araujo D, Ludwig J, Ravi V, Patel S et al (2010) Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor. Ann Oncol 21(10):2107–2111CrossRefGoogle Scholar
  3. 3.
    Kramer K, Wolf S, Mayer B, Schmidt S, Agaimy A, Henne-Bruns D et al (2015) Frequency, spectrum and prognostic impact of additional malignancies in patients with gastrointestinal stromal tumours. Neoplasia 17(1):134–140CrossRefGoogle Scholar
  4. 4.
    Gupta P, Tewari M, Shukla HS (2008) Gastrointestinal stromal tumor. SurgOncol 17:129–138Google Scholar
  5. 5.
    Fuller CE, Williams GT (1991) Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen’s disease). Histopathology 19:1–11CrossRefGoogle Scholar
  6. 6.
    Carney JA (1983) The triad of gastric epithelioidleiomyosarcoma, pulmonary chondroma, and functioning extra-adrenal paraganglioma: a five-year review. Medicine (Baltimore) 62:159–169CrossRefGoogle Scholar
  7. 7.
    Carney JA, Sheps SG, Go VL, Gordon H (1977) The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma. N Engl J Med 296:1517–1518CrossRefGoogle Scholar
  8. 8.
    Murphy JD, Ma GL, Baumgartner JM, Madlensky L, Burgoyne AM, Tang et al (2015) Increased risk of additional cancers among patients with gastrointestinal stromal tumours: a population-based study. Cancer 121(17):2960–2967. CrossRefGoogle Scholar
  9. 9.
    Huang C-T et al (2014) MicroRNA-mediated networks underlie immune response regulation in papillary thyroid carcinoma. Sci Rep 4:6495 WebCrossRefGoogle Scholar
  10. 10.
    Ou W-b et al (2008) Protein Kinase C Theta (PKCθ) regulates KIT expression and proliferation in gastrointestinal stromal tumourS. Oncogene 27.42:5624–5634 PMC. Web. 17 July 2015CrossRefGoogle Scholar
  11. 11.
    Wei W, Lu Z, Li D, Wang Y, Zhu Y, Wang Z et al (2014) Association of the miR-149 Rs2292832 polymorphism with papillary thyroid cancer risk and clinicopathologic characteristics in a Chinese population. IJMS 15(11):20968–20981CrossRefGoogle Scholar

Copyright information

© Indian Association of Surgical Oncology 2019

Authors and Affiliations

  1. 1.Department of Surgical GastroenterologyJagjivanram HospitalMumbaiIndia
  2. 2.Department of GI SurgeryMedica Superspecialty HospitalKolkataIndia
  3. 3.Department of SurgeryDM WIMS Medical CollegeWayanadIndia

Personalised recommendations